医学
内科学
危险系数
肥厚性心肌病
心房颤动
糖尿病
心力衰竭
冲程（发动机）
心源性猝死
比例危险模型
置信区间
队列
队列研究
人口
心脏病学
倾向得分匹配
内分泌学
工程类
环境卫生
机械工程
作者
Mi‐Hyang Jung,Jung Sun Cho,So‐Young Lee,Jong‐Chan Youn,Young Choi,Woo‐Baek Chung,Jungkuk Lee,Dongwoo Kang,Woojin Kwon,Tae‐Seok Kim,Sang‐Hyun Ihm,Hae Ok Jung
标识
DOI：10.1093/eurjpc/zwae345
摘要
Hypertrophic cardiomyopathy (HCM) is associated with a significant risk of arrhythmia and heart failure (HF), yet treatment options for patients with HCM have remained limited. We aimed to investigate the relationship between sodium-glucose cotransporter-2 inhibitor (SGLT2i) use and clinical outcomes among patients with concurrent HCM and diabetes in real-world settings.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
GingerF
null
Criminology34
殷勤的紫槐
劉浏琉
Frank
Mic
YifanWang
RC_Wang
寻道图强
54Darren
HJJHJH
无极微光
MchemG
Cooper
Qwering
andrele
Xhhaai
jiaaaaa
NattyPoe
Maestro_S
LaTeXer
GU
专注的问寒
皖公网安备34019202002308
